IMV Inc.
OTC: IMVIQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrew Hall
- Employees
- 63
- Headquarters
- Dartmouth, Canada
- IPO year
- 2009
- Market cap
- $117.0
- Website
- https://www.imv-inc.com
Loading IMVIQ…
Loading profile data…Frequently asked questions about IMVIQ
What does IMV Inc. (IMVIQ) do?
IMV Inc. is a biotechnology firm focused on developing cancer treatments, currently in the clinical trial phase. It leverages its proprietary DPX immune-modulating technology platform to create a range of therapeutic candidates aimed at both solid and blood-related cancers. Its primary investigational therapy, maveropepimut-S, is an immunotherap...
Where does IMVIQ trade?
IMV Inc. (IMVIQ) trades on the Other OTC.
What sector is IMVIQ in?
IMV Inc. (IMVIQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of IMV Inc.?
Andrew Hall is the chief executive officer of IMV Inc. (IMVIQ).
Where is IMV Inc. headquartered?
IMV Inc. is headquartered in Canada.
Does IMVIQ pay a dividend?
IMV Inc. (IMVIQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IMVIQ go public?
IMV Inc. (IMVIQ) completed its initial public offering in 2009.